Male Hypogonadism Market Size to Grow by USD 684.95 Mn, AbbVie Inc. and Bayer AG Among Key Vendors - Technavio
Male Hypogonadism Market Size to Grow by USD 684.95 Mn, AbbVie Inc. and Bayer AG Among Key Vendors - Technavio
NEW YORK, Sept. 19, 2022 /PRNewswire/ -- The male hypogonadism market has been segmented by type (Klinefelter syndrome, Kallmann syndrome, and pituitary disorders) and geography (North America, Europe, Asia, and Rest of World (ROW)). North America will account for 37% of the market's growth during the forecast period. This growth is attributed to factors such as the significant increase in the prevalence of male hypogonadism. Moreover, market growth in this region will be faster than the growth of the market in other regions. The US and Canada are the key countries for the male hypogonadism market in North America.
纽约，9月2022年19号/美通社/--男性性腺功能减退症市场已按类型(Klinefelter综合征、Kallmann综合征和垂体疾病)和地理位置(北美、欧洲、亚洲和世界其他地区(排))。北美将在预测期内占市场增长的37%。这一增长归因于男性性腺功能低下症患病率显著增加等因素。此外，该地区的市场增长将快于其他地区的市场增长。美国和加拿大是#年男性性腺功能减退市场的主要国家。北美.
The male hypogonadism market size is estimated to grow by USD 684.95 mn from 2021 to 2026. In addition, the growth momentum of the market will accelerate at a CAGR of 5.09% during the forecast period.
据估计，从2021年到2026年，男性性腺功能减退的市场规模将增长684.95美元。此外，在预测期内，市场的增长势头将以5.09%的复合年均增长率加速。
Technavio provides a comprehensive report summary describing the market size and forecast along with research methodology. The FREE sample report is available in PDF format
Technavio提供了一份全面的报告摘要，描述了市场规模和预测以及研究方法。免费样本报告以PDF格式提供
The male hypogonadism market report includes information on the product launches, sustainability, and prospects of leading vendors, including AbbVie Inc., Aytu BioPharma Inc., Bayer AG, Bio Techne Corp., Diurnal Group Plc, Eli Lilly and Co., Endo International Plc, Ferring B.V., IBSA Institute Biochimique SA, Lipocine Inc., Merck and Co. Inc., Perrigo Co. Plc, Pfizer Inc., and Teva Pharmaceutical Industries Ltd. The key offerings of some of these vendors are listed below:
男性性腺功能减退市场报告包括领先供应商的产品推出、可持续性和前景的信息，这些供应商包括艾伯维公司公司、爱图生物制药公司、拜耳公司、Bio Techne公司、Diurial Group Plc、礼来、Endo International Plc、Ferring B.V.、IBSA Institute BioChimique SA、利普辛公司、默克公司、Perrigo Co.PLC、辉瑞和Teva制药工业有限公司。其中一些供应商的主要产品如下：
- AbbVie Inc. - The company offers male hypogonadism treatment, through its Testosterone Gel.
- Bayer AG - The company offers Hormone-replacement therapies, which can help men with testosterone deficiency and improve their mental and physical well-being, sexual satisfaction, and quality of life.
- Eli Lilly and Co. - The company offers treatment of testosterone deficiency (hypogonadism) in men, through its AXIRON testosterone solution.
- Endo International Plc - The company offers treatment of testosterone deficiency (hypogonadism) in men through testosterone replacement therapy.
- Ferring B.V. - The company offers Testavan treatment options for men with hypogonadism, which is designed to enhance bioavailability. It is administered with a convenient hands-free applicator.
- IBSA Institute Biochimique SA - The company offers treatment of testosterone deficiency through its subsidiary, IBSA Pharma SAS.
- 艾伯维公司。-该公司通过其睾丸素凝胶提供男性性腺功能减退的治疗。
- 拜耳股份公司该公司提供激素替代疗法，可以帮助患有睾丸素缺乏的男性，改善他们的身心健康、性满意度和生活质量。
- 礼来。-该公司通过其AxIron睾丸素解决方案提供男性睾丸素缺乏(性腺功能减退)的治疗。
- 远藤国际公司-该公司通过睾酮替代疗法治疗男性睾丸素缺乏(性腺功能减退)。
- 费林B.V.-该公司为性腺功能减退的男性提供Testavan治疗选项，旨在提高生物利用度。它是通过一个方便的免提涂布器进行管理的。
- IBSA研究所生物嵌合体SA-该公司通过其子公司IBSA Pharma SAS提供治疗睾丸素缺乏的药物。
Technavio's reports provide key strategic initiatives used by vendors, along with key news and the latest developments. View our FREE PDF Sample Report Now
Technavio的报告提供了供应商使用的关键战略举措，以及关键新闻和最新发展。立即查看我们的免费PDF示例报告
The competitive scenario provided in the male hypogonadism market report analyzes, evaluates, and positions companies based on various performance indicators. Some of the factors considered for this analysis include the financial performance of companies over the past few years, growth strategies, product innovations, new product launches, investments, growth in market share, etc.
男性性腺功能减退症市场报告中提供的竞争情景基于各种业绩指标对公司进行分析、评估和定位。本分析考虑的一些因素包括公司过去几年的财务业绩、增长战略、产品创新、新产品的推出、投资、市场份额的增长等。
Factors such as an increase in the incidence of hypogonadism and the increasing awareness about male hypogonadism and its treatment options will be crucial in driving the growth of the market. However, the loss of patent exclusivities and increasing generic competition will restrict the market growth.
性腺功能减退症发病率增加以及人们对男性性腺功能减退症及其治疗选择的认识日益提高等因素，将是推动市场增长的关键因素。然而，专利排他性的丧失和日益加剧的仿制药竞争将制约市场增长。
Technavio has identified key trends, drivers, and challenges in the market, which will help vendors improve their strategies to stay ahead of their competitors. View our FREE PDF Sample Report
Technavio已经确定了市场中的主要趋势、驱动因素和挑战，这将帮助供应商改进他们的战略，以保持领先于竞争对手。查看我们的免费PDF示例报告
Sexually Transmitted Diseases (STD) Treatment Market by Service and Geography - Forecast and Analysis 2022-2026: The sexually transmitted diseases (STD) treatment market share is expected to increase by USD 13.48 billion from 2021 to 2026.
按服务和地域划分的性传播疾病(STD)治疗市场-2022-2026年预测与分析：从2021年到2026年，性传播疾病(STD)治疗市场份额预计将增加134.8亿美元。
Sexual Enhancement Supplements Market by Product and Geography - Forecast and Analysis 2022-2026: The sexual enhancement supplements market share is expected to increase by USD 801.29 million from 2021 to 2026.
按产品和地域划分的性增强补充剂市场-2022-2026年预测与分析：2021年至2026年，性增强补充剂的市场份额预计将增加8.0129亿美元。
|
Male Hypogonadism Market Scope | |
|
Report Coverage |
Details |
|
Page number |
120 |
|
Base year |
2021 |
|
Forecast period |
2022-2026 |
|
Growth momentum & CAGR |
Accelerate at a CAGR of 5.09% |
|
Market growth 2022-2026 |
USD 684.95 million |
|
Market structure |
Fragmented |
|
YoY growth (%) |
3.52 |
|
Regional analysis |
North America, Europe, Asia, and Rest of World (ROW) |
|
Performing market contribution |
North America at 37% |
|
Key consumer countries |
US, Canada, Germany, UK, and China |
|
Competitive landscape |
Leading companies, competitive strategies, consumer engagement scope |
|
Companies profiled |
AbbVie Inc., Aytu BioPharma Inc., Bayer AG, Bio Techne Corp., Diurnal Group Plc, Eli Lilly and Co., Endo International Plc, Ferring B.V., IBSA Institute Biochimique SA, Lipocine Inc., Merck and Co. Inc., Perrigo Co. Plc, Pfizer Inc., and Teva Pharmaceutical Industries Ltd. |
|
Market Dynamics |
Parent market analysis, market growth inducers and obstacles, fast-growing and slow-growing segment analysis, COVID-19 impact and future consumer dynamics, and market condition analysis for the forecast period. |
|
Customization purview |
If our report has not included the data that you are looking for, you can reach out to our analysts and get segments customized. |
|
男性性腺功能减退症的市场范围 | |
|
报告覆盖范围 |
细节 |
|
页码 |
120 |
|
基准年 |
2021 |
|
预测期 |
2022-2026 |
|
增长动能和复合年增长率 |
以5.09%的复合年均增长率加速 |
|
2022-2026年市场增长 |
6.8495亿美元 |
|
市场结构 |
支离破碎 |
|
同比增长(%) |
3.52 |
|
区域分析 |
北美、欧洲、亚洲和世界其他地区(行) |
|
业绩市场贡献 |
北美为37% |
|
主要消费国 |
美国、加拿大、德国、英国和中国 |
|
竞争格局 |
领先公司、竞争战略、消费者参与范围 |
|
公司简介 |
艾伯维公司、Aytu BioPharma Inc.、拜耳股份公司、Bio Techne Corp.、DAURNAL Group Plc、礼来、Endo International Plc、Ferring B.V.、IBSA Institute BioChimique SA、利普辛公司、默克公司、Perrigo Co.PLC、辉瑞和Teva制药工业有限公司。 |
|
市场动态 |
母市场分析，市场增长诱因和障碍，快增长和慢增长细分市场分析，新冠肺炎影响和未来消费者动态，以及预测期内的市场状况分析。 |
|
自定义权限 |
如果我们的报告没有包括您正在寻找的数据，您可以联系我们的分析师并定制细分市场。 |
Browse Health Care Market Reports
浏览医疗市场报告
1 Executive Summary
1执行摘要
- 1.1 Market overview
- Exhibit 01: Executive Summary – Chart on Market Overview
- Exhibit 02: Executive Summary – Data Table on Market Overview
- Exhibit 03: Executive Summary – Chart on Global Market Characteristics
- Exhibit 04: Executive Summary – Chart on Market by Geography
- Exhibit 05: Executive Summary – Chart on Market Segmentation by Type
- Exhibit 06: Executive Summary – Chart on Incremental Growth
- Exhibit 07: Executive Summary – Data Table on Incremental Growth
- Exhibit 08: Executive Summary – Chart on Vendor Market Positioning
- 1.1市场概述
- 图01：执行摘要-市场概览图表
- 图02：执行摘要-市场概览数据表
- 图03：执行摘要--全球市场特征图表
- 图04：执行摘要-按地域划分的市场图表
- 图05：执行摘要-按类型划分的市场细分图表
- 图06：执行摘要-增量增长图表
- 图07：执行摘要-增量增长数据表
- 图08：执行摘要-供应商市场定位图表
2 Market Landscape
2市场格局
- 2.1 Market ecosystem
- Exhibit 09: Parent market
- Exhibit 10: Market Characteristics
- 2.1市场生态系统
- 图09：母市场
- 图表10：市场特征
3 Market Sizing
3市场规模调整
- 3.1 Market definition
- Exhibit 11: Offerings of vendors included in the market definition
- 3.1市场定义
- 表11：市场定义中包括的供应商的产品
- 3.2 Market segment analysis
- Exhibit 12: Market segments
- 3.2细分市场分析
- 图12：细分市场
- 3.3 Market size 2021
- 3.3 2021年市场规模
- 3.4 Market outlook: Forecast for 2021-2026
- Exhibit 13: Chart on Global - Market size and forecast 2021-2026 ($ million)
- Exhibit 14: Data Table on Global - Market size and forecast 2021-2026 ($ million)
- Exhibit 15: Chart on Global Market: Year-over-year growth 2021-2026 (%)
- Exhibit 16: Data Table on Global Market: Year-over-year growth 2021-2026 (%)
- 3.4市场展望：2021-2026年预测
- 图表13：2021-2026年全球市场规模及预测图表(百万美元)
- 图表14：2021-2026年全球市场规模及预测数据表(百万美元)
- 图表15：全球市场图表：2021-2026年同比增长(%)
- 图表16：全球市场数据表：2021-2026年同比增长(%)
4 Five Forces Analysis
四、五力分析
- 4.1 Five forces summary
- Exhibit 17: Five forces analysis - Comparison between2021 and 2026
- 4.1五力总结
- 图17：五力分析--2021年与2026年的对比
- 4.2 Bargaining power of buyers
- Exhibit 18: Chart on Bargaining power of buyers – Impact of key factors 2021 and 2026
- 4.2买家的议价能力
- 图表18：买家议价能力图表--2021年和2026年关键因素的影响
- 4.3 Bargaining power of suppliers
- Exhibit 19: Bargaining power of suppliers – Impact of key factors in 2021 and 2026
- 4.3供应商的议价能力
- 图表19：供应商议价能力--2021年和2026年关键因素的影响
- 4.4 Threat of new entrants
- Exhibit 20: Threat of new entrants – Impact of key factors in 2021 and 2026
- 4.4新进入者的威胁
- 图20：新进入者的威胁--2021年和2026年关键因素的影响
- 4.5 Threat of substitutes
- Exhibit 21: Threat of substitutes – Impact of key factors in 2021 and 2026
- 4.5替补球员的威胁
- 图21：替代品的威胁--2021年和2026年关键因素的影响
- 4.6 Threat of rivalry
- Exhibit 22: Threat of rivalry – Impact of key factors in 2021 and 2026
- 4.6竞争威胁
- 图22：竞争的威胁--2021年和2026年关键因素的影响
- 4.7 Market condition
- Exhibit 23: Chart on Market condition - Five forces 2021 and 2026
- 4.7市况
- 图表23：2021年和2026年五股力量行情图表
5 Market Segmentation by Type
5按类型划分的市场细分
- 5.1 Market segments
- Exhibit 24: Chart on Type - Market share 2021-2026 (%)
- Exhibit 25: Data Table on Type - Market share 2021-2026 (%)
- 5.1细分市场
- 图表24：2021-2026年类型-市场份额图表(%)
- 图25：2021-2026年类型-市场份额数据表(%)
- 5.2 Comparison by Type
- Exhibit 26: Chart on Comparison by Type
- Exhibit 27: Data Table on Comparison by Type
- 5.2按类型比较
- 图26：按类型进行比较的图表
- 图27：按类型比较的数据表
- 5.3 Klinefelters syndrome - Market size and forecast 2021-2026
- Exhibit 28: Chart on Klinefelters syndrome - Market size and forecast 2021-2026 ($ million)
- Exhibit 29: Data Table on Klinefelters syndrome - Market size and forecast 2021-2026 ($ million)
- Exhibit 30: Chart on Klinefelters syndrome - Year-over-year growth 2021-2026 (%)
- Exhibit 31: Data Table on Klinefelters syndrome - Year-over-year growth 2021-2026 (%)
- 5.3 Klinefelters综合征--市场规模和2021-2026年预测
- 图表28：Klinefelters综合征图表--市场规模和2021-2026年预测(百万美元)
- 图表29：Klinefelters综合征数据表--市场规模和2021-2026年预测(百万美元)
- 图表30：Klinefelters综合征图表-2021-2026年同比增长(%)
- 图表31：Klinefelters综合征数据表--2021-2026年间的年增长率(%)
- 5.4 Kallmann syndrome - Market size and forecast 2021-2026
- Exhibit 32: Chart on Kallmann syndrome - Market size and forecast 2021-2026 ($ million)
- Exhibit 33: Data Table on Kallmann syndrome - Market size and forecast 2021-2026 ($ million)
- Exhibit 34: Chart on Kallmann syndrome - Year-over-year growth 2021-2026 (%)
- Exhibit 35: Data Table on Kallmann syndrome - Year-over-year growth 2021-2026 (%)
- 5.4卡尔曼综合征--市场规模和2021-2026年预测
- 图表32：卡尔曼综合症图表--市场规模和2021-2026年预测(百万美元)
- 图表33：Kallmann综合征数据表--市场规模和2021-2026年预测(百万美元)
- 图表34：Kallmann综合征图表--2021-2026年同比增长(%)
- 图表35：Kallmann综合征数据表--2021-2026年间的年增长率(%)
- 5.5 Pituitary disorders - Market size and forecast 2021-2026
- Exhibit 36: Chart on Pituitary disorders - Market size and forecast 2021-2026 ($ million)
- Exhibit 37: Data Table on Pituitary disorders - Market size and forecast 2021-2026 ($ million)
- Exhibit 38: Chart on Pituitary disorders - Year-over-year growth 2021-2026 (%)
- Exhibit 39: Data Table on Pituitary disorders - Year-over-year growth 2021-2026 (%)
- 5.5垂体性疾病--市场规模和2021-2026年预测
- 图表36：垂体性疾病图表--2021-2026年市场规模和预测(百万美元)
- 图表37：垂体性疾病数据表--2021-2026年市场规模和预测(百万美元)
- 图表38：垂体性疾病图表--2021-2026年间的年增长率(%)
- 图表39：垂体性疾病数据表--2021-2026年的年增长率(%)
- 5.6 Market opportunity by Type
- Exhibit 40: Market opportunity by Type ($ million)
- 5.6按类型划分的市场机会
- 图表40：按类型划分的市场机会(百万美元)
6 Customer Landscape
6客户环境
- 6.1 Customer landscape overview
- Exhibit 41: Analysis of price sensitivity, lifecycle, customer purchase basket, adoption rates, and purchase criteria
- 6.1客户环境概述
- 图41：价格敏感度、生命周期、客户购物篮、采用率和购买标准分析
7 Geographic Landscape
7地理景观
- 7.1 Geographic segmentation
- Exhibit 42: Chart on Market share by geography 2021-2026 (%)
- Exhibit 43: Data Table on Market share by geography 2021-2026 (%)
- 7.1地理分段
- 图表42：2021-2026年按地域划分的市场份额图表(%)
- 图43：2021-2026年按地域划分的市场份额数据表(%)
- 7.2 Geographic comparison
- Exhibit 44: Chart on Geographic comparison
- Exhibit 45: Data Table on Geographic comparison
- 7.2地理位置比较
- 图44：地理对比图表
- 图45：地理对比数据表
- 7.3 North America - Market size and forecast 2021-2026
- Exhibit 46: Chart on North America - Market size and forecast 2021-2026 ($ million)
- Exhibit 47: Data Table on North America - Market size and forecast 2021-2026 ($ million)
- Exhibit 48: Chart on North America - Year-over-year growth 2021-2026 (%)
- Exhibit 49: Data Table on North America - Year-over-year growth 2021-2026 (%)
- 7.3 北美-市场规模和2021-2026年预测
- 图46：图表北美-市场规模和2021-2026年预测(百万美元)
- 图47：数据表北美-市场规模和2021-2026年预测(百万美元)
- 图表48：图表北美-2021-2026年同比增长(%)
- 图49：数据表北美-2021-2026年同比增长(%)
- 7.4 Europe - Market size and forecast 2021-2026
- Exhibit 50: Chart on Europe - Market size and forecast 2021-2026 ($ million)
- Exhibit 51: Data Table on Europe - Market size and forecast 2021-2026 ($ million)
- Exhibit 52: Chart on Europe - Year-over-year growth 2021-2026 (%)
- Exhibit 53: Data Table on Europe - Year-over-year growth 2021-2026 (%)
- 7.4 欧洲-市场规模和2021-2026年预测
- 图表50：图表欧洲-市场规模和2021-2026年预测(百万美元)
- 图51：数据表欧洲-市场规模和2021-2026年预测(百万美元)
- 图52：图表欧洲-2021-2026年同比增长(%)
- 图53：数据表欧洲-2021-2026年同比增长(%)
- 7.5 Asia - Market size and forecast 2021-2026
- Exhibit 54: Chart on Asia - Market size and forecast 2021-2026 ($ million)
- Exhibit 55: Data Table on Asia - Market size and forecast 2021-2026 ($ million)
- Exhibit 56: Chart on Asia - Year-over-year growth 2021-2026 (%)
- Exhibit 57: Data Table on Asia - Year-over-year growth 2021-2026 (%)
- 7.5 亚洲-市场规模和2021-2026年预测
- 图54：图表亚洲-市场规模和2021-2026年预测(百万美元)
- 图55：数据表亚洲-市场规模和2021-2026年预测(百万美元)
- 图56：图表亚洲-2021-2026年同比增长(%)
- 图57：数据表亚洲-2021-2026年同比增长(%)
- 7.6 Rest of World (ROW) - Market size and forecast 2021-2026
- Exhibit 58: Chart on Rest of World (ROW) - Market size and forecast 2021-2026 ($ million)
- Exhibit 59: Data Table on Rest of World (ROW) - Market size and forecast 2021-2026 ($ million)
- Exhibit 60: Chart on Rest of World (ROW) - Year-over-year growth 2021-2026 (%)
- Exhibit 61: Data Table on Rest of World (ROW) - Year-over-year growth 2021-2026 (%)
- 7.6世界其他地区(ROW)--市场规模和2021-2026年预测
- 图表58：世界其他地区图表(行)-2021-2026年市场规模和预测(百万美元)
- 图表59：世界其他地区数据表(行)--2021-2026年市场规模和预测(百万美元)
- 图表60：2021-2026年世界其他地区同比增长图表(行)(%)
- 图表61：世界其他地区(ROW)-2021-2026年同比增长数据表(%)
- 7.7 US - Market size and forecast 2021-2026
- Exhibit 62: Chart on US - Market size and forecast 2021-2026 ($ million)
- Exhibit 63: Data Table on US - Market size and forecast 2021-2026 ($ million)
- Exhibit 64: Chart on US - Year-over-year growth 2021-2026 (%)
- Exhibit 65: Data Table on US - Year-over-year growth 2021-2026 (%)
- 7.7美国-2021-2026年市场规模和预测
- 图表62：美国市场规模和2021-2026年预测图表(百万美元)
- 图表63：美国2021-2026年市场规模及预测数据表(百万美元)
- 图表64：美国2021-2026年同比增长图表(%)
- 图表65：美国2021-2026年同比增长数据表(%)
- 7.8 Germany - Market size and forecast 2021-2026
- Exhibit 66: Chart on Germany - Market size and forecast 2021-2026 ($ million)
- Exhibit 67: Data Table on Germany - Market size and forecast 2021-2026 ($ million)
- Exhibit 68: Chart on Germany - Year-over-year growth 2021-2026 (%)
- Exhibit 69: Data Table on Germany - Year-over-year growth 2021-2026 (%)
- 7.8 德国-市场规模和2021-2026年预测
- 图表66：图表德国-市场规模和2021-2026年预测(百万美元)
- 图67：数据表德国-市场规模和2021-2026年预测(百万美元)
- 图表68：图表德国-2021-2026年同比增长(%)
- 图69：数据表德国-2021-2026年同比增长(%)
- 7.9 China - Market size and forecast 2021-2026
- Exhibit 70: Chart on China - Market size and forecast 2021-2026 ($ million)
- Exhibit 71: Data Table on China - Market size and forecast 2021-2026 ($ million)
- Exhibit 72: Chart on China - Year-over-year growth 2021-2026 (%)
- Exhibit 73: Data Table on China - Year-over-year growth 2021-2026 (%)
- 7.9 中国-市场规模和2021-2026年预测
- 图表70：图表中国-市场规模和2021-2026年预测(百万美元)
- 图71：数据表中国-市场规模和2021-2026年预测(百万美元)
- 图72：图表中国-2021-2026年同比增长(%)
- 图73：数据表中国-2021-2026年同比增长(%)
- 7.10 UK - Market size and forecast 2021-2026
- Exhibit 74: Chart on UK - Market size and forecast 2021-2026 ($ million)
- Exhibit 75: Data Table on UK - Market size and forecast 2021-2026 ($ million)
- Exhibit 76: Chart on UK - Year-over-year growth 2021-2026 (%)
- Exhibit 77: Data Table on UK - Year-over-year growth 2021-2026 (%)
- 7.10英国-市场规模和预测2021-2026
- 图表74：英国市场规模和2021-2026年预测图表(百万美元)
- 图表75：英国市场规模数据表及2021-2026年预测(百万美元)
- 图表76：英国2021-2026年同比增长图表(%)
- 图表77：英国2021-2026年同比增长数据表(%)
- 7.11 Canada - Market size and forecast 2021-2026
- Exhibit 78: Chart on Canada - Market size and forecast 2021-2026 ($ million)
- Exhibit 79: Data Table on Canada - Market size and forecast 2021-2026 ($ million)
- Exhibit 80: Chart on Canada - Year-over-year growth 2021-2026 (%)
- Exhibit 81: Data Table on Canada - Year-over-year growth 2021-2026 (%)
- 7.11 加拿大-市场规模和2021-2026年预测
- 图表78：图表加拿大-市场规模和2021-2026年预测(百万美元)
- 图79：数据表加拿大-市场规模和2021-2026年预测(百万美元)
- 图表80：图表加拿大-2021-2026年同比增长(%)
- 图81：数据表加拿大-2021-2026年同比增长(%)
- 7.12 Market opportunity by geography
- Exhibit 82: Market opportunity by geography ($ million)
- 7.12按地理位置划分的市场机会
- 图表82：按地理位置划分的市场机会(百万美元)
8 Drivers, Challenges, and Trends
8个驱动因素、挑战和趋势
- 8.1 Market drivers
- 8.1市场驱动因素
- 8.2 Market challenges
- 8.2市场挑战
- 8.3 Impact of drivers and challenges
- Exhibit 83: Impact of drivers and challenges in 2021 and 2026
- 8.3驱动因素和挑战的影响
- 图83：2021年和2026年驱动因素和挑战的影响
- 8.4 Market trends
- 8.4市场趋势
9 Vendor Landscape
9供应商情况
- 9.1 Overview
- 9.1概述
- 9.2 Vendor landscape
- Exhibit 84: Overview on Criticality of inputs and Factors of differentiation
- 9.2供应商景观
- 图84：关于投入的关键程度和区分因素的概览
- 9.3 Landscape disruption
- Exhibit 85: Overview on factors of disruption
- 9.3景观破坏
- 图85：中断因素概览
- 9.4 Industry risks
- Exhibit 86: Impact of key risks on business
- 9.4行业风险
- 图表86：关键风险对业务的影响
10 Vendor Analysis
10供应商分析
- 10.1 Vendors covered
- Exhibit 87: Vendors covered
- 10.1涵盖的供应商
- 图表87：涵盖的供应商
- 10.2 Market positioning of vendors
- Exhibit 88: Matrix on vendor position and classification
- 10.2供应商的市场定位
- 图表88：关于供应商地位和分类的矩阵
- 10.3 AbbVie Inc.
- Exhibit 89: AbbVie Inc. - Overview
- Exhibit 90: AbbVie Inc. - Product / Service
- Exhibit 91: AbbVie Inc. - Key offerings
- 10.3艾伯维公司。
- 证据89：艾伯维公司。-概览
- 证据90：艾伯维公司--产品/服务
- 证物91：艾伯维公司--主要产品
- 10.4 Bayer AG
- Exhibit 92: Bayer AG - Overview
- Exhibit 93: Bayer AG - Business segments
- Exhibit 94: Bayer AG - Key offerings
- Exhibit 95: Bayer AG - Segment focus
- 10.4拜耳股份公司
- 图92：拜耳股份公司-概览
- 图93：拜耳股份公司--业务细分
- 图94：拜耳股份公司-主要产品
- 图95：拜耳股份公司-细分市场焦点
- 10.5 Eli Lilly and Co.
- Exhibit 96: Eli Lilly and Co. - Overview
- Exhibit 97: Eli Lilly and Co. - Product / Service
- Exhibit 98: Eli Lilly and Co. - Key offerings
- 10.5礼来。
- 证据96：礼来。-概览
- 证据97：礼来--产品/服务
- 证物98：礼来--主要产品
- 10.6 Endo International Plc
- Exhibit 99: Endo International Plc - Overview
- Exhibit 100: Endo International Plc - Business segments
- Exhibit 101: Endo International Plc - Key news
- Exhibit 102: Endo International Plc - Key offerings
- Exhibit 103: Endo International Plc - Segment focus
- 10.6远藤国际公司
- 展览99：Endo International Plc-概览
- 图100：Endo International Plc-Business细分市场
- 展品101：远藤国际公司-关键新闻
- 展览102：Endo International Plc-Key Products
- 图103：Endo International Plc-细分市场焦点
- 10.7 Ferring B.V.
- Exhibit 104: Ferring B.V. - Overview
- Exhibit 105: Ferring B.V. - Product / Service
- Exhibit 106: Ferring B.V. - Key offerings
- 10.7费林B.V.
- 展品104：Ferring B.V.-概览
- 图105：Ferring B.V.-产品/服务
- 展品106：Ferring B.V.-主要产品
- 10.8 IBSA Institute Biochimique SA
- Exhibit 107: IBSA Institute Biochimique SA - Overview
- Exhibit 108: IBSA Institute Biochimique SA - Product / Service
- Exhibit 109: IBSA Institute Biochimique SA - Key offerings
- 10.8 IBSA研究所生物嵌合体SA
- 展览107：IBSA研究所生物嵌合体SA-概览
- 图108：IBSA研究所生物嵌合体SA-产品/服务
- 图109：IBSA研究所生物嵌合体SA-主要产品
- 10.9 Lipocine Inc.
- Exhibit 110: Lipocine Inc. - Overview
- Exhibit 111: Lipocine Inc. - Product / Service
- Exhibit 112: Lipocine Inc. - Key offerings
- 10.9利普林公司。
- 展览110：利普西因公司-概览
- 展品111：利培林公司--产品/服务
- 展品112：利普西林公司-主要产品
- 10.10 Merck and Co. Inc.
- Exhibit 113: Merck and Co. Inc. - Overview
- Exhibit 114: Merck and Co. Inc. - Business segments
- Exhibit 115: Merck and Co. Inc. - Key news
- Exhibit 116: Merck and Co. Inc. - Key offerings
- Exhibit 117: Merck and Co. Inc. - Segment focus
- 10.10默克公司
- 图表113：默克公司-概览
- 图114：默克公司-业务部门
- 证据115：默克公司-关键新闻
- 图116：默克公司-主要产品
- 图117：默克公司-细分市场焦点
- 10.11 Pfizer Inc.
- Exhibit 118: Pfizer Inc. - Overview
- Exhibit 119: Pfizer Inc. - Product / Service
- Exhibit 120: Pfizer Inc. - Key news
- Exhibit 121: Pfizer Inc. - Key offerings
- 10.11辉瑞。
- 证据：辉瑞。-概览
- 图119：辉瑞--产品/服务
- 证物120：辉瑞--关键新闻
- 图121：辉瑞--主要产品
- 10.12 Teva Pharmaceutical Industries Ltd.
- Exhibit 122: Teva Pharmaceutical Industries Ltd. - Overview
- Exhibit 123: Teva Pharmaceutical Industries Ltd. - Business segments
- Exhibit 124: Teva Pharmaceutical Industries Ltd. - Key news
- Exhibit 125: Teva Pharmaceutical Industries Ltd. - Key offerings
- Exhibit 126: Teva Pharmaceutical Industries Ltd. - Segment focus
- 10.12 Teva制药工业有限公司
- 图122：Teva制药工业有限公司-概览
- 图123：Teva制药工业有限公司--业务部门
- 展览124：Teva制药工业有限公司-主要新闻
- 图125：Teva制药工业有限公司-主要产品
- 图126：Teva制药工业有限公司--细分市场焦点
11 Appendix
11附录
- 11.1 Scope of the report
- 11.1报告的范围
- 11.2 Inclusions and exclusions checklist
- Exhibit 127: Inclusions checklist
- Exhibit 128: Exclusions checklist
- 11.2包括和排除清单
- 图127：包含物清单
- 图128：排除清单
- 11.3 Currency conversion rates for US$
- Exhibit 129: Currency conversion rates for US$
- 11.3美元的货币兑换率
- 图表129：美元的货币兑换率
- 11.4 Research methodology
- Exhibit 130: Research methodology
- Exhibit 131: Validation techniques employed for market sizing
- Exhibit 132: Information sources
- 11.4研究方法
- 图130：研究方法
- 图131：用于市场规模确定的验证技术
- 图表132：信息来源
- 11.5 List of abbreviations
- Exhibit 133: List of abbreviations
- 11.5缩略语列表
- 图表133：缩略语列表
Technavio is a leading global technology research and advisory company. Their research and analysis focus on emerging market trends and provide actionable insights to help businesses identify market opportunities and develop effective strategies to optimize their market positions. With over 500 specialized analysts, Technavio's report library consists of more than 17,000 reports and counting, covering 800 technologies, spanning across 50 countries. Their client base consists of enterprises of all sizes, including more than 100 Fortune 500 companies. This growing client base relies on Technavio's comprehensive coverage, extensive research, and actionable market insights to identify opportunities in existing and potential markets and assess their competitive positions within changing market scenarios.
Technavio是一家全球领先的技术研究和咨询公司。他们的研究和分析侧重于新兴市场趋势，并提供可操作的见解，帮助企业识别市场机会并制定有效战略，以优化其市场地位。Technavio的报告库拥有500多名专业分析师，由17,000多份报告和报告组成，涵盖50个国家和地区的800项技术。他们的客户群包括各种规模的企业，其中包括100多家财富500强公司。不断增长的客户基础依赖于Technavio的全面覆盖、广泛的研究和可操作的市场洞察力，以确定现有和潜在市场中的机会，并评估它们在不断变化的市场情景中的竞争地位。
Contact
联系方式
Technavio Research
Jesse Maida
Media & Marketing Executive
US: +1 844 364 1100
UK: +44 203 893 3200
Email: [email protected]
Website:
技术研究
杰西·迈达
媒体与营销主管
美国：+1 844 364 1100
英国：+44 203 893 3200
电子邮件：[受电子邮件保护]
网站：
SOURCE Technavio
来源技术